Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02073123
Title Study of IDO Inhibitor in Combination With Ipilimumab for Adult Patients With Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Augusta University Augusta Georgia 30912 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
New Mexico Cancer Center Alliance Albuquerque New Mexico 87106 United States Details
Penn State Hershey Cancer Institue Hershey Pennsylvania 17033 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field